Pharmacogenomic-guided drug development: regulatory perspective
Authors:
- 1 January 2002
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 2 (1) , 20-24
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studyThe Lancet, 2000
- The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1998
- Apparent racial difference in response to angiotensin I infusionEuropean Journal of Clinical Pharmacology, 1990
- Ethnic differences in response to beta-blockade: Fact or artefact? A study with bisoprolol and propranololEuropean Journal of Clinical Pharmacology, 1988